EDGAR Filing Documents for 0001193125-08-042215

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-08-042215

Filing Date

2008-02-29

Accepted

2008-02-28 19:51:24

Documents

Period of Report

2007-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	d20f.htm	20-F	1769366
2	SUBSIDIARIES OF THE REGISTRANT	dex8.htm	EX-8	17037
3	CONSENT OF KESSELMAN & KESSELMAN	dex10.htm	EX-10	2625
4	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302	dex12i.htm	EX-12.(I)	8991
5	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302	dex12ii.htm	EX-12.(II)	8992
6	CERTIFICATION OF THE CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350	dex13.htm	EX-13	4235
	Complete submission text file	0001193125-08-042215.txt		1812685

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)